News & Analysis on Clinical Trial Services & Contract Research And Development
Update
After finding cGMP violations at another Ranbaxy plant in India, the US FDA on Monday issued an import alert that effectively stops all of the plant’s drug shipments from entering the US.
Johnson & Johnson is battling another onset of quality concerns as its subsidiary Janssen is pulling one lot of its Risperdal Consta injection in the US due to a mold contamination.
Aspen Pharma saw its revenue increase over the past year by almost 30% and is now looking to further expand its manufacturing capabilities.
Soon sponsors and CROs seeking ethical approval for clinical trials in the UK will have to register them in a public database under the HRA's transparency plan.
Theorem Clinical Research and CRL (Charles River Laboratories) have partnered to help clients transition between preclinical and clinical testing.
Aurobindo Pharma has given more details of a planned expansion of its API and antibiotics businesses and has confirmed its intention to rejig its injectables operations.